What is AEON stock price today?

Visit our real-time dashboard for the current AEON stock price and live market data.

Is AEON stock going up or down today?

AEON stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy AEON stock now?

The decision to buy AEON depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is AEON a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for AEON based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is AEON stock overvalued or undervalued?

AEON currently trades at a P/E ratio of 0.00, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if AEON is fairly priced.

What is AEON's P/E ratio?

AEON has a price-to-earnings (P/E) ratio of 0.00, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is AEON's market cap?

AEON (AEON Biopharma, Inc.) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is AEON's price to book ratio?

Price-to-book ratio for AEON is available on our dashboard along with other valuation metrics.

Does AEON pay dividends?

AEON does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is AEON's dividend yield?

AEON does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is AEON stock a good long-term investment?

AEON's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is AEON's revenue growth rate?

Revenue growth data for AEON is available on our dashboard with detailed financial statement analysis.

Profitability metrics for AEON are available on our dashboard with complete income statement analysis.

What are the risks of investing in AEON?

Key risks for AEON include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does AEON compare to its competitors?

Compare AEON to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize AEON's performance and positioning.

What is AEON's stock price target for 2026?

Visit our prediction page for AI-powered price targets for AEON with bull, base, and bear case scenarios.

What do analysts say about AEON?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for AEON. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is AEON's next earnings report?

AEON reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

AEON - AEON Biopharma, Inc.

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About AEON Biopharma, Inc.

AEON Biopharma, Inc. (AEON) common stock

Price Chart

Loading chart...

AEON Key Statistics

Market Cap

$8.59M

P/E Ratio

0.00

How AEON Compares to Peers

AEON has the lowest P/E ratio in Biotechnology, suggesting it may be the most undervalued

AEON is the smallest among peers, which may offer higher growth potential

P/E Rank

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
AEON(This stock)	$8.59M	0.0	0%	0.0%	-
AMGNAmgen Inc	$163.61B	27.4	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN

Data Updated: June 6, 2026 at 1:08 AM EDT

Ready to invest in AEON?

Commission-free trading available. Affiliate links.

AEON Lician Score

5% confidence

4.0/10

Neutral

AEON has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates AEONacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

AEON Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for AEON

Dashboard

Enter a ticker to analyze